ICO Public Sale. PDA Working Group meeting – Invites to attend to CQC, MHRA, GPhC, LPC, Pharma wholesale and retail industry.
Commence contract with the ASC to support the Nottingham Trial and UK roll out programme.
Collaboration with Local Pharmacy Groups and membership committee to inform on pilot and expand reach to 20 further pharmacies in Nottingham, Derby & Leicester.
Publish trial research and outcomes – present at PDA meeting to CQC, MHRA. GPhC, LPC and Industry.
The MediConnect platform will demonstrate an improved duty of care and detection that will see a reduction in pharmacy insurance for Pharmacies.
Will see the recruitment of 500 UK Pharmacies join MediConnect through the expansion of the ASC membership in the UK.
Aim for MediConnect to be the Industry standard solution for traceability of drugs for recall and counterfeit medication detection.
The ASC achieves it’s goal of UK Pharmacies required to be members of the ASC and the MediConenct platform is used by all UK pharmacies.